Your browser doesn't support javascript.
loading
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART.
Hermans, Lucas E; Steegen, Kim; Ter Heine, Rob; Schuurman, Rob; Tempelman, Hugo A; Moraba, Robert; van Maarseveen, Erik; Nijhuis, Monique; Pillay, Taryn; Legg-E'Silva, Derryn; Snyman, Tracy; Schapiro, Jonathan M; Burger, David M; Carmona, Sergio; Wensing, Annemarie Mj.
Afiliación
  • Hermans LE; Virology, Department of Medical Microbiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
  • Steegen K; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa.
  • Ter Heine R; Ndlovu Research Consortium, Elandsdoorn, South Africa.
  • Schuurman R; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Tempelman HA; Department of Molecular Medicine and Haematology, National Health Laboratory Service (NHLS), Johannesburg, South Africa.
  • Moraba R; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Maarseveen E; Virology, Department of Medical Microbiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
  • Nijhuis M; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa.
  • Pillay T; Ndlovu Research Consortium, Elandsdoorn, South Africa.
  • Legg-E'Silva D; Ndlovu Research Consortium, Elandsdoorn, South Africa.
  • Snyman T; Clinical Pharmacology, UMCU, The Netherlands.
  • Schapiro JM; Virology, Department of Medical Microbiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
  • Burger DM; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa.
  • Carmona S; Ndlovu Research Consortium, Elandsdoorn, South Africa.
  • Wensing AM; Department of Chemistry, University of the Witwatersrand, Johannesburg, South Africa.
J Int AIDS Soc ; 23(6): e25501, 2020 06.
Article en En | MEDLINE | ID: mdl-32515898
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Insuficiencia del Tratamiento / Inhibidores de la Proteasa del VIH Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Insuficiencia del Tratamiento / Inhibidores de la Proteasa del VIH Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos